"Mutation burden" trang 1 - tải miễn phí từ tailieunhanh
NIMBus: A negative binomial regression based integrative method for mutation burden analysis

NIMBus: A negative binomial regression based integrative method for mutation burden analysis
25    55    1
Impact of JAK2V617F mutation burden on disease phenotype in Chinese patients with JAK2V617F-positive Polycythemia vera (PV) and Essential thrombocythemia (ET)

Impact of JAK2V617F mutation burden on disease phenotype in Chinese patients with JAK2V617F-positive Polycythemia vera (PV) and Essential thrombocythemia (ET)
7    75    0
A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer

A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer
12    35    1
Gene expression and immune infiltration in melanoma patients with different mutation burden

Gene expression and immune infiltration in melanoma patients with different mutation burden
12    25    1
Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer

Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer
13    48    1
Radiomic assessment as a method for predicting tumor mutation burden (TMB) of bladder cancer patients: A feasibility study

Radiomic assessment as a method for predicting tumor mutation burden (TMB) of bladder cancer patients: A feasibility study
9    30    1
The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced nonsmall cell lung cancer: A systematic review and meta-analysis

The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced nonsmall cell lung cancer: A systematic review and meta-analysis
17    41    1
Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing

Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing
11    37    1
Repeat-induced point mutation in Neurospora crassa causes the highest known mutation rate and mutational burden of any cellular life

Repeat-induced point mutation in Neurospora crassa causes the highest known mutation rate and mutational burden of any cellular life
23    56    1
Network Evolution Model-based prediction of tumor mutation burden from radiomic-clinical features in endometrial cancers

Network Evolution Model-based prediction of tumor mutation burden from radiomic-clinical features in endometrial cancers
13    1    1
Bias and inconsistency in the estimation of tumour mutation burden

Bias and inconsistency in the estimation of tumour mutation burden
9    1    1
The prognostic role of tumor mutation burden on survival of breast cancer: A systematic review and meta-analysis

The prognostic role of tumor mutation burden on survival of breast cancer: A systematic review and meta-analysis
12    1    1
SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy

SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy
12    1    1
An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers

An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers
16    68    0
First insight into the somatic mutation burden of neurofibromatosis type 2- associated grade I and grade II meningiomas: A case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation

First insight into the somatic mutation burden of neurofibromatosis type 2- associated grade I and grade II meningiomas: A case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation
10    73    1
The aetiology and burden of myeloproliferative neoplasms in the United Kingdom: The MyelOproliferative neoplasmS: An In-depth case-control (MOSAICC) study protocol

The aetiology and burden of myeloproliferative neoplasms in the United Kingdom: The MyelOproliferative neoplasmS: An In-depth case-control (MOSAICC) study protocol
9    3    1
The neoepitope landscape of breast cancer: Implications for immunotherapy

The neoepitope landscape of breast cancer: Implications for immunotherapy
10    36    1
Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial

Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial
8    49    1
Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma

Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma
19    29    1
Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients

Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients
20    1    1